The Sachkundige Person is the role that certifies and releases medicinal product batches in Germany: the German equivalent of the European Qualified Person, governed by § 14 of the Arzneimittelgesetz (AMG). If you work in QA, QC or manufacturing and are looking at the German market — Europe's largest pharmaceutical market — becoming a Qualified Person in Germany means understanding three things: the education and experience requirements set by § 15 AMG, the appointment mechanism tied to the manufacturing authorisation, and the operational responsibilities that flow from Annex 16 of the EU GMP. This article walks through the full path, with verified regulatory references.
Who the Sachkundige Person is under § 14 AMG
§ 14 AMG establishes that the manufacturing authorisation (Herstellungserlaubnis) may only be granted if the holder has at least one person qualifying as a Sachkundige Person within the meaning of § 14 Abs. 1 Nr. 1 AMG. Without a designated Sachkundige Person, a German pharmaceutical manufacturing site simply cannot operate: her presence is a condition of the authorisation, not an organisational option.
The foundation is European: Directive 2001/83/EC, in Articles 48 and 49, requires every Member State to demand that the manufacturing authorisation holder have a Qualified Person at their disposal, and defines the minimum requirements for studies and experience. The German legislator transposed these requirements into § 15 AMG (Sachkenntnis), adding some national specifics we will look at shortly.
The Sachkenntnis requirements: § 15 AMG
§ 15 AMG defines "Sachkenntnis", i.e. the combination of academic qualification and practical experience that qualifies a person as sachkundig. Two routes are recognised:
- Approbation als Apotheker: the German licence to practise as a pharmacist satisfies the academic requirement on its own;
- a university degree in pharmacy, chemistry, pharmaceutical chemistry, biology, human medicine or veterinary medicine, completed by the required practical experience.
The practical experience must be gained in the qualitative and quantitative analysis of medicinal products and in quality control, and its duration depends on the length of the course of study, following the scheme also laid down in Art. 49 of Directive 2001/83/EC:
| Course of study | Practical experience required |
|---|---|
| Degree in one of the recognised disciplines (standard duration) | At least 2 years in qualitative and quantitative analysis of medicinal products |
| University course of at least 5 years | May be reduced to 1 year |
| University course of at least 6 years | May be reduced to 6 months |
| Blood products, sera, vaccines and allergens (§ 15 Abs. 3) | Additional requirements: up to 3 years of experience in medical serology or medical microbiology |
| ATMPs – advanced therapy medicinal products (§ 15 Abs. 3a) | Specific experience in biotechnology, microbiology or virology (2–3 years depending on the category) |
Watch out for a point that often causes confusion in interviews: the experience that counts for § 15 AMG is analytical, not generically "in manufacturing". Years spent in production or quality assurance are valuable for performing the role well, but they do not replace the period of activity in the analysis of medicinal products required by law.
Topics like this one — regulated roles, regulatory requirements, differences between markets — are the daily bread of The Pragmatic GMP, GuideGxP's free weekly newsletter: one practical, no-fluff analysis every week, written for people working in QA, QC and regulatory. Subscribe so you don't miss the next ones.
How the appointment works: the Anzeige to the Land authority
Unlike other countries, Germany has neither a national register of Sachkundige Personen nor a dedicated state examination. The qualification is demonstrated through documentation within the authorisation procedure: it is the holder of the Herstellungserlaubnis who designates the Sachkundige Person and notifies her (Anzeige) to the competent supervisory authority of the Land — for example the territorially competent Regierungspräsidium or Bezirksregierung — attaching the evidence of Sachkenntnis: degree certificate, attestations of practical experience, Approbation where applicable.
The authority verifies the requirements and may refuse or suspend the authorisation if the designated person does not possess the required qualification or reliability. Any change of Sachkundige Person must be notified promptly. In practice, "becoming" a Sachkundige Person coincides with the first formal designation in an authorised company: that is the step that turns paper requirements into a legally recognised role.
Operational responsibilities: batch certification and Annex 16
Once appointed, the Sachkundige Person exercises the functions that Directive 2001/83/EC assigns to the Qualified Person and that Annex 16 of the EU GMP details operationally: certifying that each batch has been manufactured and tested in compliance with the Herstellungserlaubnis, GMP and the marketing authorisation, before release to the market. The certification is recorded in a batch register that must remain available to the authority.
In day-to-day practice this means: reviewing the batch record and deviations, evaluating analytical results and OOS cases, verifying the supply chain (including importation from third countries), managing the interface with QA and production and, in the cases provided for by Annex 16, assessing unexpected deviations. The responsibility is personal: the Sachkundige Person's signature cannot be delegated upwards or diluted into the quality system.
Typical mistakes of those aiming for the role
- Confusing the DACH roles: the German Sachkundige Person (§ 14 AMG) and the Swiss fachtechnisch verantwortliche Person (FvP, Swissmedic) are different figures, with different legal bases and scopes — Switzerland is not in the EU and has its own regime.
- Underestimating the analytical requirement: planning a career only in production or QA without a period in medicinal product analysis leaves the Sachkenntnis incomplete.
- Ignoring the special rules: for blood products, vaccines and ATMPs, § 15 Abs. 3 and 3a AMG require specific additional experience; the "standard" path is not enough.
- Neglecting technical German: correspondence with the Länder authorities and site documentation are in German; without command of the regulatory terminology (Herstellungserlaubnis, Anzeige, Sachkenntnis) the role is hard to exercise.
GuideGxP recommendation
If your goal is the Sachkundige Person role, build the path backwards: first check that your degree is among those recognised by § 15 AMG, then plan a documented period of activity in qualitative and quantitative analysis of medicinal products (obtaining detailed attestations of duties and duration), and in the meantime master Annex 16, because that is the text you will be measured against every day. If you already work in a company based in Germany, talk to the incumbent Sachkundige Person: shadowing batch review is the most concrete way to prepare for the responsibility of the signature.
To go deeper into the craft of batch certification, GuideGxP's Qualified Person (QP) Operational Guide – Annex 16 / Batch Release turns regulatory requirements into a clear, documented decision process you can reconstruct in an audit.
